Optimized Drug Treatment Reduces Mortality in Acute Type A Aortic Dissection Patients

A multicenter retrospective cohort study has revealed that optimized drug treatment (ODT) significantly improves survival outcomes for patients with acute type A aortic dissection (ATAAD) who cannot undergo surgical intervention. The research, conducted across Beijing Anzhen Hospital and Beijing Dawanglu Emergency Rescue Hospital, provides critical insights for managing this life-threatening cardiovascular emergency.

Study Design and Patient Population

The study analyzed 572 ATAAD patients admitted between January and December 2024, ultimately including 184 patients in the final analysis after excluding those who underwent surgery, were transferred to other facilities, or died before treatment initiation. Of these, 52 patients received ODT while 132 patients were managed with non-ODT approaches.

ATAAD represents a cardiovascular emergency with mortality rates of approximately 50% within the first 48 hours and 1-2% per hour. The condition involves tearing of the aortic intima, with high-pressure blood flowing into the media, potentially leading to aortic rupture and sudden death.

Optimized Drug Treatment Protocol

The ODT strategy was developed based on current guidelines and clinical expertise from various medical specialists. The protocol required immediate intensive care unit admission with continuous invasive blood pressure monitoring and implementation of several key interventions:

• Strict blood pressure control: Target systolic blood pressure below 120 mmHg using intravenous β-blockers as first-line therapy, with vasodilators added if blood pressure remained elevated
• Heart rate management: Target range of 60-80 beats per minute to prevent aortic dissection propagation
• Pain control: Adequate analgesia using opiates
• Anti-impulse therapy: Intravenous β-blockers unless contraindicated

Common medications utilized included esmolol infusion, intravenous labetalol, nicardipine, nitroprusside, and opiates. The non-ODT group received blood pressure and heart rate control but without strict guideline supervision.

Significant Mortality Reduction

The study demonstrated substantial survival benefits for patients receiving ODT. In crude analysis, ODT was associated with significantly lower 30-day mortality (HR = 0.5, 95% CI 0.3-0.9, P = 0.010) and total mortality (HR = 0.6, 95% CI 0.4-0.9, P = 0.024). These protective effects remained significant after adjusting for multiple potential covariates.

Overall mortality rates differed markedly between groups: 23 patients (44.2%) died in the ODT group compared to 83 patients (62.9%) in the non-ODT group. Kaplan-Meier survival analysis confirmed significantly lower mortality in the ODT group (log-rank, P = 0.023).

Subgroup Analysis and Treatment Adherence

Forest plot analysis revealed that ODT decreased mortality risk across various patient subgroups, regardless of age, sex, comorbidities, or left ventricular ejection fraction. Landmark analysis using 30 days as the cut-off point showed significantly lower mortality in the ODT group during the initial 30-day period (log-rank, P = 0.03), with no significant difference in survival rates thereafter.

The ODT group demonstrated superior adherence to guideline-recommended targets. More patients in the ODT group received β-blockers, vasoactive drugs, diuretics, α1 blockers, and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers. Additionally, higher proportions of ODT patients achieved target blood pressure and heart rate parameters.

Clinical Context and Global Implications

Current guidelines recommend surgical procedures as primary treatment for ATAAD, but many patients cannot receive timely surgery due to financial constraints, surgical risks, or lack of nearby capable medical centers, particularly in developing countries. According to the Sino-RAD study, China's largest aortic dissection registry, the ATAAD surgery rate is only 52.6%, substantially lower than the 82.2% reported in the International Register of Aortic Dissection.

The researchers noted that many medical centers still have surgery rates below 50%, representing a significant population at risk. Patients who do not undergo surgery often lack adequate medical assistance, remaining at constant risk of sudden death from aortic rupture.

Study Limitations and Future Directions

The authors acknowledged several limitations, including the retrospective observational design and relatively small sample size, though they noted it represents one of the largest studies in ATAAD conservative care. Patient selection bias may have influenced results, as many patients avoiding surgery did so due to non-medical factors including financial burden, surgical risk concerns, or personal preferences.

Despite extensive covariate adjustment during Cox regression analysis, unmeasured confounding variables may have impacted results. The researchers suggested that randomized controlled trials with strict inclusion and exclusion criteria would provide additional validation.

Clinical Implications

The findings suggest ODT represents a viable noninvasive approach that can significantly reduce mortality risk for ATAAD patients who refuse surgical treatment or lack surgical eligibility. In resource-limited regions where surgery is not readily available, this treatment strategy should be promoted and strictly implemented to increase guideline compliance rates.

The researchers emphasized that ODT is more convenient for medical institutions and more psychologically acceptable to patients and their families compared to surgical intervention, potentially improving overall patient care in challenging clinical scenarios.